Latest News

Despite considerable progress in the past decades, societies continue to fail to meet the healthcare needs of women at key moments in their lives.

TruScreen Limited (NZX:TRU) is pleased to announce the appointment of Ms Victoria Potarina as Chief Executive Officer, commencing 2 March 2020.

Cervical cancer is epidemic in India, with 77,300 new cases diagnosed each year and 37,800 deaths resulting from the disease—a fatality rate of 49 per…

China manufacturing approvals expected to provide TruScreen greater market access. Local manufacturing contracts in China under negotiation with expected reduction in component costs. Novel Coronavirus…

"A novel diagnostic device for cervical cancer screening in India."

More cases of cervical cancer are diagnosed in China each year than in any other nation. China accounts for about 20 per cent of all…

Zimbabwe may be known for its pristine wilderness, but it is also a country facing a major public health crisis in the form of high…

TruScreen’s breakthrough cervical cancer screening device is a viable and attractive alternative to traditional cervical screening methods.

TruScreen is pleased to provide a copy of its November 2019 Stakeholder newsletter.

Cervical cancer affects millions of women worldwide. It is a silent killer, it has a high prevalence outside of developed countries, and almost all cases…